Fingerprint
Dive into the research topics of 'Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically